Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

782 Press Releases
DateTitleCompany
30 Jun 15 Total Voting Rights Update Circassia Pharmaceuticals,
Published by
PharmiWeb.com
30 Jun 15 Roche’s ocrelizumab significantly reduced both relapses and disability progression versus interferon beta-1a (Rebif®) in two Phase III studies in multiple sclerosis Roche,
Published by
PharmiWeb.com
30 Jun 15 Lophius Biosciences Launches T-Track® ImmunoScan Kit and T-activated® ImmunoScan Cocktail for Monitoring Immune Function in Immunosuppressed Patients Lophius Biosciences,
Published by
PharmiWeb.com
30 Jun 15 Multiplicom launches a new test for the diagnosis of chronic lymphocytic leukemia Multiplicom,
Published by
PharmiWeb.com
30 Jun 15 Merck Serono Introduces New Eeva Test Version Aiming for Optimized Assisted Reproductive Outcomes Merck Serono,
Published by
PharmiWeb.com
30 Jun 15 ABLYNX AND TAISHO SIGN EXCLUSIVE LICENSE AGREEMENT FOR THE DEVELOPMENT AND COMMERCIALISATION OF ANTI-TNFa NANOBODY (OZORALIZUMAB) IN JAPAN ABLYNX,
Published by
PharmiWeb.com
30 Jun 15 CIRCASSIA’S EXTENDED OFFER PERIOD FOR AEROCRINE HAS INCREASED ACCEPTANCES TO 97.2 PERCENT Circassia Pharmaceuticals,
Published by
PharmiWeb.com
30 Jun 15 TONIC LIFE COMMUNICATIONS APPOINTED THE GLOBAL PR AGENCY FOR THE EUROPEAN CONNECTED HEALTH ALLIANCE Tonic Life Communications,
Published by
PharmiWeb.com
30 Jun 15 Genentech’s ocrelizumab Significantly Reduced Both Relapses and Disability Progression versus interferon beta-1a (Rebif®) in Two Phase III Studies in Multiple Sclerosis Genentech,
Published by
PharmiWeb.com
30 Jun 15 Celgene and Juno Announce Ten-Year Collaboration to Advance Potentially Groundbreaking Immunotherapies for Patients with Cancer and Autoimmune Diseases Celgene,
Published by
PharmiWeb.com
30 Jun 15 Alimera Sciences To Present At Cantor Fitzgerald Inaugural Healthcare Conference Alimera Sciences,
Published by
PharmiWeb.com
30 Jun 15 Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication Regeneron Pharmaceuticals,
Published by
PharmiWeb.com
30 Jun 15 STELARA® Receives European Commission Approval For Treatment Of Adolescents With Moderate-To-Severe Psoriasis In Europe Janssen-Cilag International NV,
Published by
PharmiWeb.com
30 Jun 15 BioMarin Announces FDA Accepts Drisapersen NDA for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping BioMarin Pharmaceutical,
Published by
PharmiWeb.com
29 Jun 15 Axxess Pharma Prepares for Strong Revenue Growth in 2nd Half of 2015 Fueled by Their Latest Line of Tapout Products and Up-Listing to the OTCQB Stock Exchange / Financial Audits to Be Completed and Submitted to FINRA Within 30 Days Axxess Pharma,
Published by
PharmiWeb.com
29 Jun 15 Advaxis's President and Chief Executive Officer Daniel J. O'Connor Receives 2015 Ernst & Young Entrepreneur Of The Year® in New Jersey Advaxis,
Published by
PharmiWeb.com
29 Jun 15 AntriaBio Appoints David F. Welch, Ph.D. to Its Board of Directors AntriaBio,
Published by
PharmiWeb.com
29 Jun 15 Zosano Announces $15 Million Debt Financing Zosano Pharma Corporation,
Published by
PharmiWeb.com
29 Jun 15 Contract Research Organization WCCT Global Receives Large Investment from Asian Equity Firm WCCT Global,
Published by
PharmiWeb.com
29 Jun 15 Barda Exercises $3 MM in Additional Contract Funding for Development of AEOL 10150 as Treatment for Acute Radiation Syndrome Aeolus Pharmaceuticals,
Published by
PharmiWeb.com
29 Jun 15 Eli Lilly and Co On Track To Extend Reach In Immunotherapies Market Eli Lilly,
Published by
PharmiWeb.com
29 Jun 15 Amag Pharma to buy world's largest stem cell bank for $700 mln Amag Pharma,
Published by
PharmiWeb.com
29 Jun 15 Novartis announces publication in The Lancet showing sustained efficacy with secukinumab over one year in psoriatic arthritis patients Novartis,
Published by
PharmiWeb.com
29 Jun 15 Osteoporosis linked with heart disease in older people University of Southampton,
Published by
PharmiWeb.com
29 Jun 15 Re-inventing the finger The Institute of Cancer Research,
Published by
PharmiWeb.com
29 Jun 15 PROTON PARTNERS INTERNATIONAL ACQUIRES SITE FOR UK’S FIRST PROTON BEAM THERAPY CANCER TREATMENT CENTRE Proton Partners International Limited,
Published by
PharmiWeb.com
29 Jun 15 Merck Announces Phase 3 Study of Single-Dose EMEND® (fosaprepitant dimeglumine) for Injection Regimen Met Primary Endpoint in Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy Merck,
Published by
PharmiWeb.com
29 Jun 15 A new case study is out showing how FUJIFILM Diosynth Biotechnologies (Fujifilm) engaged MHRA early to future-proof mammalian cell culture manufacturing facility. UK MHRA,
Published by
PharmiWeb.com
29 Jun 15 Going the extra mile for epilepsy in Africa UCB,
Published by
PharmiWeb.com
29 Jun 15 Much of England may experience “heatwave” conditions from Tuesday this week. Public Health England offers advice on staying safe in the heat. Public Health England UK,
Published by
PharmiWeb.com
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.